Table 1 Demographics table for all patients and then stratified into whether they were taking anticoagulation at diagnosis of COVID-19
| Â | Â | Overall | Anticoagulation | p | |
|---|---|---|---|---|---|
No | Yes | ||||
N | Â | 1032 | 868 | 164 | Â |
Age |  | 71 (56–83) | 68 (54–82) | 80 (70–85) | < 0.001 |
Sex | Male | 569 (55.1) | 485 (55.9) | 84 (51.2) | 0.311 |
Ethnicity | White | 725 (70.3) | 586 (67.6) | 139 (84.8) | < 0.001 |
Asian | 116 (11.3) | 106 (12.2) | 10 (6.1) | Â | |
Black | 94 (9.1) | 88 (10.1) | 6 (3.7) | Â | |
Mixed | 14 (1.4) | 14 (1.6) | 0 (0.0) | Â | |
Other | 28 (2.7) | 28 (3.2) | 0 (0.0) | Â | |
Unknown | 54 (5.2) | 45 (5.2) | 9 (5.5) | Â | |
CCI Score |  | 1 (0–2) | 1 (0–2) | 2 (1–3) | < 0.001 |
Myocardial Infarction | Â | 83 (8.9) | 61 (7.8) | 22 (14.3) | 0.015 |
Congestive Heart Failure |  | 129 (13.8) | 77 (9.9) | 52 (33.8) | < 0.001 |
Peripheral Vascular Disease | Â | 64 (6.9) | 50 (6.4) | 14 (9.1) | 0.304 |
Cerebrovascular disease | Â | 45 (4.8) | 38 (4.9) | 7 (4.5) | 1.000 |
Dementia | Â | 157 (16.8) | 128 (16.4) | 29 (18.8) | 0.538 |
COPD | Â | 259 (27.7) | 212 (27.2) | 47 (30.5) | 0.455 |
Rheumatoid Disease | Â | 23 (2.5) | 16 (2.1) | 7 (4.5) | 0.123 |
Peptic Ulcer Disease | Â | 9 (1.0) | 8 (1.0) | 1 (0.6) | 1.000 |
Mild Liver Disease | Â | 30 (3.2) | 30 (3.8) | 0 (0.0) | 0.026 |
Diabetes without complications | Â | 237 (25.4) | 191 (24.5) | 46 (29.9) | 0.193 |
Diabetes with complications | Â | 36 (3.9) | 29 (3.7) | 7 (4.5) | 0.796 |
Hemi or Paraplegia | Â | 17 (1.8) | 12 (1.5) | 5 (3.2) | 0.263 |
Renal Disease | Â | 144 (15.4) | 109 (14.0) | 35 (22.7) | 0.009 |
Mod/Severe Liver Disease | Â | 12 (1.3) | 12 (1.5) | 0 (0.0) | 0.247 |
Cancer | Â | 72 (7.7) | 51 (6.5) | 21 (13.6) | 0.004 |
Metastatic cancer | Â | 24 (2.6) | 14 (1.8) | 10 (6.5) | 0.002 |
AIDS | Â | 1 (0.1) | 1 (0.1) | 0 (0.0) | 1.000 |
Hypertension | Â | 457 (44.3) | 372 (42.9) | 85 (51.8) | 0.042 |